Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Accenture CEO sells 9.2K shares, Chairman sells 10.9K shares of common stock » 18:11
10/20/20
10/20
18:11
10/20/20
18:11
ACN

Accenture

$230.54 /

+4.165 (+1.84%)

In a regulatory filing,…

In a regulatory filing, Accenture disclosed that its CEO Julie Sweet sold 9.2K shares of common stock, chairman David Rowland sold 10.9K shares of common stock, and CFO Kathleen McClue sold 2.3K shares of common stock. The total of the three transactions was about $5.1M.

ShowHide Related Items >><<
ACN Accenture
$230.54 /

+4.165 (+1.84%)

ACN Accenture
$230.54 /

+4.165 (+1.84%)

09/28/20 Barclays
Accenture price target lowered to $245 from $260 at Barclays
09/25/20 JPMorgan
Accenture price target lowered to $252 from $256 at JPMorgan
09/25/20 Citi
Accenture earnings weakness a buying opportunity, says Citi
09/22/20 UBS
Accenture assumed with a Neutral at UBS
ACN Accenture
$230.54 /

+4.165 (+1.84%)

ACN Accenture
$230.54 /

+4.165 (+1.84%)

ACN Accenture
$230.54 /

+4.165 (+1.84%)

ACN Accenture
$230.54 /

+4.165 (+1.84%)

Monday
Hot Stocks
Best Buy, Accenture collaborate to advance Best Buy technology strategy » 05:14
10/19/20
10/19
05:14
10/19/20
05:14
BBY

Best Buy

$119.37 /

-1.16 (-0.96%)

, ACN

Accenture

$230.14 /

+1.48 (+0.65%)

Best Buy (BBY) and…

Best Buy (BBY) and Accenture (ACN) are teaming to advance Best Buy's strategic priorities. Over the next five years, the two companies will work together to advance Best Buy's technology strategy, delivery and operations, including work in data science, information security, product development, technology risk management and user experience design. Best Buy has a goal to hire 1,000 employees to its digital and technology team, and it has committed that 30% of these employees will be diverse. Accenture will support Best Buy in this work by helping recruit, train and hire new talent. Accenture and Best Buy will jointly invest in technology innovation focused on helping Best Buy create enhanced customer experiences, drive incremental value from its existing operations and accelerate growth in areas like health and membership programs. Accenture will provide Best Buy access to its world-class learning and development programs, including its library of online training courses and its intensive, 12-week training boot camps for emerging talent.

ShowHide Related Items >><<
BBY Best Buy
$119.37 /

-1.16 (-0.96%)

ACN Accenture
$230.14 /

+1.48 (+0.65%)

BBY Best Buy
$119.37 /

-1.16 (-0.96%)

10/05/20 Exane BNP Paribas
Best Buy initiated with an Outperform at Exane BNP Paribas
09/29/20 Cleveland Research
Best Buy upgraded to Buy from Neutral at Cleveland Research
09/29/20 Cleveland Research
Best Buy upgraded to Buy from Neutral at Cleveland Research
09/01/20 Loop Capital
Best Buy pricing narrows relative to Amazon.com, says Loop Capital
ACN Accenture
$230.14 /

+1.48 (+0.65%)

09/28/20 Barclays
Accenture price target lowered to $245 from $260 at Barclays
09/25/20 JPMorgan
Accenture price target lowered to $252 from $256 at JPMorgan
09/25/20 Citi
Accenture earnings weakness a buying opportunity, says Citi
09/22/20 UBS
Accenture assumed with a Neutral at UBS
BBY Best Buy
$119.37 /

-1.16 (-0.96%)

ACN Accenture
$230.14 /

+1.48 (+0.65%)

BBY Best Buy
$119.37 /

-1.16 (-0.96%)

ACN Accenture
$230.14 /

+1.48 (+0.65%)

BBY Best Buy
$119.37 /

-1.16 (-0.96%)

ACN Accenture
$230.14 /

+1.48 (+0.65%)

BBY Best Buy
$119.37 /

-1.16 (-0.96%)

ACN Accenture
$230.14 /

+1.48 (+0.65%)

Over a week ago
Hot Stocks
Accenture, Takeda and Amazon enter into a strategic agreement » 07:04
10/13/20
10/13
07:04
10/13/20
07:04
ACN

Accenture

$230.49 /

+1.77 (+0.77%)

, TAK

Takeda Pharmaceutical

$17.89 /

+0.1 (+0.56%)

, AMZN

Amazon.com

$3,443.20 /

+155.2 (+4.72%)

Takeda Pharmaceutical…

Takeda Pharmaceutical (TAK), Accenture (ACN) and Amazon (AMZN) Web Services have entered into a five-year strategic agreement to accelerate Takeda's digital transformation. "By combining the power of three organizations, Takeda is making a bold move to be at the intersection of human health, technology and business growth," said Christophe Weber, Takeda president and CEO. In addition, the Plasma-Derived Therapies Business Unit, which develops critical, life-saving and life-sustaining therapies for patients with rare and complex diseases, is creating state-of-the-art, digitally-connected donation centers and modernizing the donor experience, optimizing the plasma collection process. Takeda's plans to increase its plasma collection and manufacturing capacity by at least 65% by 2024 are geared towards expanding access to essential medicines and accelerating new treatments for patients.

ShowHide Related Items >><<
TAK Takeda Pharmaceutical
$17.89 /

+0.1 (+0.56%)

AMZN Amazon.com
$3,443.20 /

+155.2 (+4.72%)

ACN Accenture
$230.49 /

+1.77 (+0.77%)

ACN Accenture
$230.49 /

+1.77 (+0.77%)

09/28/20 Barclays
Accenture price target lowered to $245 from $260 at Barclays
09/25/20 JPMorgan
Accenture price target lowered to $252 from $256 at JPMorgan
09/25/20 Citi
Accenture earnings weakness a buying opportunity, says Citi
09/22/20 UBS
Accenture assumed with a Neutral at UBS
TAK Takeda Pharmaceutical
$17.89 /

+0.1 (+0.56%)

06/18/20 RBC Capital
Neurocrine price target raised to $135 from $116 at RBC Capital
06/17/20 Oppenheimer
Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer
04/20/20 SVB Leerink
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink
03/25/20 Piper Sandler
Piper Sandler backs Overweight on 'well capitalized' Exelixis
AMZN Amazon.com
$3,443.20 /

+155.2 (+4.72%)

10/12/20 Morgan Stanley
JFrog initiated with an Equal Weight at Morgan Stanley
10/12/20 Loop Capital
Air Transport Services upgraded to Buy from Hold at Loop Capital
10/10/20 BTIG
SpartanNash economics of Amazon pact uncertain, says BTIG
10/09/20 Mizuho
Amazon.com price target raised to $4,000 from $3,700 at Mizuho
AMZN Amazon.com
$3,443.20 /

+155.2 (+4.72%)

ACN Accenture
$230.49 /

+1.77 (+0.77%)

TAK Takeda Pharmaceutical
$17.89 /

+0.1 (+0.56%)

AMZN Amazon.com
$3,443.20 /

+155.2 (+4.72%)

ACN Accenture
$230.49 /

+1.77 (+0.77%)

TAK Takeda Pharmaceutical
$17.89 /

+0.1 (+0.56%)

AMZN Amazon.com
$3,443.20 /

+155.2 (+4.72%)

ACN Accenture
$230.49 /

+1.77 (+0.77%)

TAK Takeda Pharmaceutical
$17.89 /

+0.1 (+0.56%)

AMZN Amazon.com
$3,443.20 /

+155.2 (+4.72%)

ACN Accenture
$230.49 /

+1.77 (+0.77%)

AMZN Amazon.com
$3,443.20 /

+155.2 (+4.72%)

Hot Stocks
Atlas Technical Consultants appoints Laura Strunk as CLO, Britni Aucoin as CIO » 07:05
10/08/20
10/08
07:05
10/08/20
07:05
ATCX

Atlas Technical Consultants

$9.00 /

+0.02 (+0.22%)

, USAC

USA Compression

$10.48 /

-0.06 (-0.57%)

, ACN

Accenture

$223.59 /

+2.61 (+1.18%)

Atlas Technical…

Atlas Technical Consultants (ATCX) announce Laura Strunk as the new Chief Legal Officer and Britni Aucoin as the new Chief Information Officer. Strunk previously served as Associate General Counsel and Assistant Corporate Secretary at USA Compression (USAC) Partners, LP in Austin. Aucoin, a former Digital Practice & Offering Developer Senior Manager at Accenture (ACN) North America, has worked with clients in Oil & Gas and Food & Beverage industries to develop digital strategies for operational technology and manufacturing.

ShowHide Related Items >><<
USAC USA Compression
$10.48 /

-0.06 (-0.57%)

ATCX Atlas Technical Consultants
$9.00 /

+0.02 (+0.22%)

ACN Accenture
$223.59 /

+2.61 (+1.18%)

ATCX Atlas Technical Consultants
$9.00 /

+0.02 (+0.22%)

08/11/20 DA Davidson
Atlas Technical Consultants upgraded to Buy from Neutral at DA Davidson
08/11/20 DA Davidson
Atlas Technical Consultants upgraded to Buy from Neutral at DA Davidson
07/01/20 DA Davidson
Atlas Technical Consultants initiated with a Neutral at DA Davidson
04/08/20
Atlas Technical Consultants participates in a conference call with Lake Street
USAC USA Compression
$10.48 /

-0.06 (-0.57%)

06/05/20 UBS
USA Compression upgraded to Buy from Neutral at UBS
04/24/20 JPMorgan
USA Compression downgraded to Neutral with $12 target at JPMorgan
04/24/20 JPMorgan
USA Compression downgraded to Neutral from Overweight at JPMorgan
03/17/20 B. Riley Securities
B. Riley FBR says be 'highly selective' in Oilfield Services, downgrades three
ACN Accenture
$223.59 /

+2.61 (+1.18%)

09/28/20 Barclays
Accenture price target lowered to $245 from $260 at Barclays
09/25/20 JPMorgan
Accenture price target lowered to $252 from $256 at JPMorgan
09/25/20 Citi
Accenture earnings weakness a buying opportunity, says Citi
09/22/20 UBS
Accenture assumed with a Neutral at UBS
USAC USA Compression
$10.48 /

-0.06 (-0.57%)

ATCX Atlas Technical Consultants
$9.00 /

+0.02 (+0.22%)

ACN Accenture
$223.59 /

+2.61 (+1.18%)

  • 14
    Aug
ACN Accenture
$223.59 /

+2.61 (+1.18%)

ACN Accenture
$223.59 /

+2.61 (+1.18%)

ACN Accenture
$223.59 /

+2.61 (+1.18%)

Hot Stocks
Accenture launches vaccine management solution to support COVID-19 immunization » 11:01
10/07/20
10/07
11:01
10/07/20
11:01
ACN

Accenture

$221.87 /

+0.89 (+0.40%)

Accenture announced what…

Accenture announced what it calls "a comprehensive vaccine management solution" to help government and healthcare organizations plan and develop COVID-19 vaccination programs and related distribution and communication initiatives. "The solution expands on Accenture's contact tracing capability to help public health jurisdictions meet newly released guidelines from the U.S. Centers for Disease Control and Prevention in preparation for COVID-19 vaccine distribution. It brings together Accenture's industry, analytics and consulting experience and includes components built on the Salesforce platform. Local, state and national governments as well as healthcare organizations worldwide are expected to similarly undertake planning, development, coordination, distribution and management of COVID-19 immunization programs," the company stated.

ShowHide Related Items >><<
ACN Accenture
$221.87 /

+0.89 (+0.40%)

ACN Accenture
$221.87 /

+0.89 (+0.40%)

09/28/20 Barclays
Accenture price target lowered to $245 from $260 at Barclays
09/25/20 JPMorgan
Accenture price target lowered to $252 from $256 at JPMorgan
09/25/20 Citi
Accenture earnings weakness a buying opportunity, says Citi
09/22/20 UBS
Accenture assumed with a Neutral at UBS
ACN Accenture
$221.87 /

+0.89 (+0.40%)

ACN Accenture
$221.87 /

+0.89 (+0.40%)

ACN Accenture
$221.87 /

+0.89 (+0.40%)

ACN Accenture
$221.87 /

+0.89 (+0.40%)

Hot Stocks
Accenture to acquire Avenai, terms undisclosed » 08:48
10/07/20
10/07
08:48
10/07/20
08:48
ACN

Accenture

$220.55 /

-2.995 (-1.34%)

Accenture has agreed to…

Accenture has agreed to acquire Avenai, an Ottawa-based provider of consulting and technology services. Financial terms were not disclosed. The company said that with Avenai's significant focus on the public sector market, the acquisition will enhance Accenture's capacity to drive the technology transformation taking place across the public sector in Canada. Avenai founders Chris Brennan, Mike Scotten and Brendan Timmins will join Accenture as managing directors in its strategy and consulting practice. They will continue to lead the team they helped build at Avenai and will also work with Accenture leadership across other practices to shape and pursue new business opportunities. Avenai's employees will also join Accenture's strategy and consulting practice. The acquisition is subject to customary closing conditions.

ShowHide Related Items >><<
ACN Accenture
$220.55 /

-2.995 (-1.34%)

ACN Accenture
$220.55 /

-2.995 (-1.34%)

09/28/20 Barclays
Accenture price target lowered to $245 from $260 at Barclays
09/25/20 JPMorgan
Accenture price target lowered to $252 from $256 at JPMorgan
09/25/20 Citi
Accenture earnings weakness a buying opportunity, says Citi
09/22/20 UBS
Accenture assumed with a Neutral at UBS
ACN Accenture
$220.55 /

-2.995 (-1.34%)

ACN Accenture
$220.55 /

-2.995 (-1.34%)

ACN Accenture
$220.55 /

-2.995 (-1.34%)

ACN Accenture
$220.55 /

-2.995 (-1.34%)

Hot Stocks
Accenture agrees to acquire Myrtle Consulting Group » 11:20
10/06/20
10/06
11:20
10/06/20
11:20
ACN

Accenture

$223.18 /

-0.36 (-0.16%)

Accenture announced it…

Accenture announced it has agreed to acquire Myrtle Consulting Group, an industrial operations consulting firm headquartered in Houston. "Myrtle partners with leading companies across consumer products, life sciences, chemicals, mining and other heavy manufacturing industries to produce and distribute goods in a safer, more efficient and sustainable way. The acquisition will expand Accenture's manufacturing and supply chain capabilities. Specifically, it will strengthen Accenture's ability to transform these areas for clients from initial value assessments and operating model strategies to new business processes and technology solutions," Accenture stated. Completion of the acquisition is subject to customary closing conditions. Financial terms of the acquisition were not disclosed.

ShowHide Related Items >><<
ACN Accenture
$223.18 /

-0.36 (-0.16%)

ACN Accenture
$223.18 /

-0.36 (-0.16%)

09/28/20 Barclays
Accenture price target lowered to $245 from $260 at Barclays
09/25/20 JPMorgan
Accenture price target lowered to $252 from $256 at JPMorgan
09/25/20 Citi
Accenture earnings weakness a buying opportunity, says Citi
09/22/20 UBS
Accenture assumed with a Neutral at UBS
ACN Accenture
$223.18 /

-0.36 (-0.16%)

ACN Accenture
$223.18 /

-0.36 (-0.16%)

ACN Accenture
$223.18 /

-0.36 (-0.16%)

ACN Accenture
$223.18 /

-0.36 (-0.16%)

Hot Stocks
Accenture names Bhaskar Ghosh Chief Strategy Officer » 07:51
10/05/20
10/05
07:51
10/05/20
07:51
ACN

Accenture

$222.25 /

-2.86 (-1.27%)

Accenture announced…

Accenture announced changes to its Global Management Committee, with the appointment of a new chief strategy officer and leadership moves in its U.K. and Ireland business. Bhaskar Ghosh has been named chief strategy officer, effective immediately, with responsibility for the company's strategy and investments, including ventures and acquisitions. He will continue to lead the growth strategy for Accenture's Industry X business, which includes digital manufacturing and intelligent products and platforms. Ghosh most recently served as advisor to Julie Sweet, Accenture's chief executive officer, on critical areas including growth and investment strategy, business performance, organizational effectiveness and restructuring. Previously, Ghosh was group chief executive of Accenture Technology Services, directing strategy and investments, and leading platforms, products and global technology delivery.

ShowHide Related Items >><<
ACN Accenture
$222.25 /

-2.86 (-1.27%)

ACN Accenture
$222.25 /

-2.86 (-1.27%)

09/28/20 Barclays
Accenture price target lowered to $245 from $260 at Barclays
09/25/20 JPMorgan
Accenture price target lowered to $252 from $256 at JPMorgan
09/25/20 Citi
Accenture earnings weakness a buying opportunity, says Citi
09/22/20 UBS
Accenture assumed with a Neutral at UBS
ACN Accenture
$222.25 /

-2.86 (-1.27%)

ACN Accenture
$222.25 /

-2.86 (-1.27%)

ACN Accenture
$222.25 /

-2.86 (-1.27%)

ACN Accenture
$222.25 /

-2.86 (-1.27%)

Recommendations
Accenture price target lowered to $245 from $260 at Barclays » 06:24
09/28/20
09/28
06:24
09/28/20
06:24
ACN

Accenture

$214.70 /

+0.25 (+0.12%)

Barclays analyst Ramsey…

Barclays analyst Ramsey El-Assal lowered the firm's price target on Accenture to $245 from $260 and keeps an Overweight rating on the shares following last week's earnings report.

ShowHide Related Items >><<
ACN Accenture
$214.70 /

+0.25 (+0.12%)

ACN Accenture
$214.70 /

+0.25 (+0.12%)

09/25/20 JPMorgan
Accenture price target lowered to $252 from $256 at JPMorgan
09/25/20 Citi
Accenture earnings weakness a buying opportunity, says Citi
09/22/20 UBS
Accenture assumed with a Neutral at UBS
09/22/20 Wedbush
Accenture price target raised to $255 from $240 at Wedbush
ACN Accenture
$214.70 /

+0.25 (+0.12%)

ACN Accenture
$214.70 /

+0.25 (+0.12%)

ACN Accenture
$214.70 /

+0.25 (+0.12%)

ACN Accenture
$214.70 /

+0.25 (+0.12%)

Conference/Events
UBS telecom/media & tech analyst to hold analyst/industry conference call » 10:25
09/25/20
09/25
10:25
09/25/20
10:25
AAPL

Apple

$109.21 /

+1.01 (+0.93%)

, HPQ

HP Inc.

$18.17 /

+0.025 (+0.14%)

, DELL

Dell Technologies

$64.88 /

-0.46 (-0.70%)

, VMW

VMware

$140.54 /

+0.19 (+0.14%)

, ANET

Arista Networks

$198.43 /

+0.01 (+0.01%)

, ACN

Accenture

$211.08 /

-3.37 (-1.57%)

, JNPR

Juniper

$21.26 /

+0.1 (+0.47%)

, IBM

IBM

$117.65 /

-0.41 (-0.35%)

, CSCO

Cisco

$37.86 /

+0.02 (+0.05%)

, HPE

HP Enterprise

$9.02 /

-0.105 (-1.15%)

Tech, Media & Telecom…

Tech, Media & Telecom Analyst Vogt discusses US Enterprise Hardware & Networking initiation of various companies on an Analyst/Industry conference call to be held on September 25 at 11 am.

ShowHide Related Items >><<
VMW VMware
$140.54 /

+0.19 (+0.14%)

JNPR Juniper
$21.26 /

+0.1 (+0.47%)

IBM IBM
$117.65 /

-0.41 (-0.35%)

HPQ HP Inc.
$18.17 /

+0.025 (+0.14%)

HPE HP Enterprise
$9.02 /

-0.105 (-1.15%)

DELL Dell Technologies
$64.88 /

-0.46 (-0.70%)

CSCO Cisco
$37.86 /

+0.02 (+0.05%)

ANET Arista Networks
$198.43 /

+0.01 (+0.01%)

ACN Accenture
$211.08 /

-3.37 (-1.57%)

AAPL Apple
$109.21 /

+1.01 (+0.93%)

AAPL Apple
$109.21 /

+1.01 (+0.93%)

09/25/20 Exane BNP Paribas
Exane double upgrades Qualcomm on share gains from Huawei ban
09/23/20 Jefferies
Facebook risk/reward 'remains compelling,' says Jefferies
09/22/20
UBS assumes Apple with Neutral from Buy amid 'maturing' iPhone growth
09/22/20 UBS
Apple assumed with Neutral from Buy at UBS
HPQ HP Inc.
$18.17 /

+0.025 (+0.14%)

09/22/20 UBS
HP Inc. assumed with a Buy from Neutral at UBS
09/08/20 Standpoint Research
HP Inc. upgraded to Buy from Hold at Standpoint Research
08/28/20 Loop Capital
HP Inc. price target raised to $25 from $20 at Loop Capital
08/28/20 Barclays
HP Inc. price target raised to $19 from $16 at Barclays
DELL Dell Technologies
$64.88 /

-0.46 (-0.70%)

09/22/20 UBS
Dell Technologies assumed with a Buy from Neutral at UBS
09/03/20 Northland
VMware initiated with an Outperform at Northland
08/28/20
Fly Intel: Top five analyst upgrades
08/28/20 Raymond James
Dell Technologies price target raised to $69 from $54 at Raymond James
VMW VMware
$140.54 /

+0.19 (+0.14%)

09/03/20
Fly Intel: Top five analyst initiations
08/28/20 Morgan Stanley
VMware's on-premise exposure limits upside, says Morgan Stanley
ANET Arista Networks
$198.43 /

+0.01 (+0.01%)

09/22/20 UBS
Arista Networks assumed with a Buy at UBS
08/06/20 Citi
Arista Networks selloff an 'attractive buying opportunity,' says Citi
08/05/20 Wells Fargo
Arista Networks price target raised to $230 from $215 at Wells Fargo
07/24/20 Wolfe Research
Arista Networks initiated with a Peer Perform at Wolfe Research
ACN Accenture
$211.08 /

-3.37 (-1.57%)

09/25/20 JPMorgan
Accenture price target lowered to $252 from $256 at JPMorgan
09/25/20 Citi
Accenture earnings weakness a buying opportunity, says Citi
09/22/20 UBS
Accenture assumed with a Neutral at UBS
09/22/20 Wedbush
Accenture price target raised to $255 from $240 at Wedbush
JNPR Juniper
$21.26 /

+0.1 (+0.47%)

09/22/20 UBS
Juniper assumed with a Neutral at UBS
09/11/20 Raymond James
Juniper price target raised to $28 from $27 at Raymond James
09/04/20 Morgan Stanley
Ciena price target lowered to $46 from $50 at Morgan Stanley
07/24/20 Wolfe Research
Juniper initiated with a Peer Perform at Wolfe Research
IBM IBM
$117.65 /

-0.41 (-0.35%)

09/22/20 UBS
IBM assumed with a Neutral at UBS
08/17/20 JPMorgan
IBM price target raised to $148 from $135 at JPMorgan
07/22/20 Argus
IBM upgraded to Buy from Hold at Argus
07/22/20 Argus
IBM upgraded to Buy from Hold at Argus
CSCO Cisco
$37.86 /

+0.02 (+0.05%)

09/22/20 UBS
Cisco assumed with a Neutral at UBS
09/18/20 Wolfe Research
Cisco downgraded to Peer Perform from Outperform at Wolfe Research
08/13/20 JPMorgan
Cisco price target lowered to $46 from $50 at JPMorgan
08/13/20 Barclays
Cisco guidance raises concerns about 'relative resilience,' says Barclays
HPE HP Enterprise
$9.02 /

-0.105 (-1.15%)

09/22/20 UBS
HP Enterprise assumed with a Neutral at UBS
09/08/20 Standpoint Research
HP Enterprise upgraded to Buy from Hold at Standpoint Research
08/27/20 Citi
NetApp price target raised to $39 from $37 at Citi
08/26/20 Citi
HP Enterprise price target raised to $9 from $8 at Citi
VMW VMware
$140.54 /

+0.19 (+0.14%)

JNPR Juniper
$21.26 /

+0.1 (+0.47%)

IBM IBM
$117.65 /

-0.41 (-0.35%)

HPQ HP Inc.
$18.17 /

+0.025 (+0.14%)

HPE HP Enterprise
$9.02 /

-0.105 (-1.15%)

DELL Dell Technologies
$64.88 /

-0.46 (-0.70%)

CSCO Cisco
$37.86 /

+0.02 (+0.05%)

ANET Arista Networks
$198.43 /

+0.01 (+0.01%)

ACN Accenture
$211.08 /

-3.37 (-1.57%)

AAPL Apple
$109.21 /

+1.01 (+0.93%)

VMW VMware
$140.54 /

+0.19 (+0.14%)

JNPR Juniper
$21.26 /

+0.1 (+0.47%)

IBM IBM
$117.65 /

-0.41 (-0.35%)

HPQ HP Inc.
$18.17 /

+0.025 (+0.14%)

HPE HP Enterprise
$9.02 /

-0.105 (-1.15%)

DELL Dell Technologies
$64.88 /

-0.46 (-0.70%)

CSCO Cisco
$37.86 /

+0.02 (+0.05%)

ACN Accenture
$211.08 /

-3.37 (-1.57%)

AAPL Apple
$109.21 /

+1.01 (+0.93%)

VMW VMware
$140.54 /

+0.19 (+0.14%)

JNPR Juniper
$21.26 /

+0.1 (+0.47%)

IBM IBM
$117.65 /

-0.41 (-0.35%)

HPQ HP Inc.
$18.17 /

+0.025 (+0.14%)

HPE HP Enterprise
$9.02 /

-0.105 (-1.15%)

CSCO Cisco
$37.86 /

+0.02 (+0.05%)

ANET Arista Networks
$198.43 /

+0.01 (+0.01%)

ACN Accenture
$211.08 /

-3.37 (-1.57%)

AAPL Apple
$109.21 /

+1.01 (+0.93%)

VMW VMware
$140.54 /

+0.19 (+0.14%)

JNPR Juniper
$21.26 /

+0.1 (+0.47%)

IBM IBM
$117.65 /

-0.41 (-0.35%)

HPQ HP Inc.
$18.17 /

+0.025 (+0.14%)

HPE HP Enterprise
$9.02 /

-0.105 (-1.15%)

DELL Dell Technologies
$64.88 /

-0.46 (-0.70%)

CSCO Cisco
$37.86 /

+0.02 (+0.05%)

ACN Accenture
$211.08 /

-3.37 (-1.57%)

AAPL Apple
$109.21 /

+1.01 (+0.93%)

AAPL Apple
$109.21 /

+1.01 (+0.93%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.